secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inspire Medical Systems, Inc. (INSP)
CIK:        0001609550
Form:       8-K
Filed at:   2023-02-07T23:59:59+00:00
Accession:  0001609550-23-000014
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inspire Medical posts first profitable quarter; Q4 revenue $137.9M (+76% YoY) and guides FY2023 $560-570M
--------------------------------------------------------------------------------

- Q4 2022 net income $3.2M, diluted EPS $0.10, vs. loss of $2.4M in Q4 2021.
- Q4 revenue $137.9M (76% YoY); U.S. revenue $134.3M (+78%), OUS revenue $3.6M (+28%).
- Gross margin 83.9% in Q4, down from 85.8% due to inflation and supply chain costs.
- Full year 2022 revenue $407.9M (+75% YoY); net loss $44.9M vs. $42.0M in 2021.
- FY2023 revenue guidance $560-570M (37-40% growth); expects to add 52-56 new U.S. centers per quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609550/000160955023000014/0001609550-23-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609550/000160955023000014/insp-20230207.htm
  HTML page:      https://secwatch.observer/filing/0001609550-23-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer